Pepe was among the fastest-growing meme coins, but its price has dropped about 60% from its all-time high. Pepe reached a new ATH of $0.000028 on Dec. 9. After rising in November and December, the ...
Bing Yao’s ArriVent BioPharma has inked another licensing deal with a Chinese biopharma. The late-stage oncology biotech is picking up a new antibody-drug conju ...
We look forward to collaborating with Lepu Biopharma in advancing this program globally.” Ziye Sui, Ph.D., Executive Director and Chief Executive Officer of Lepu Biopharma added, “We are very pleased ...
The latest involves handing Lepu Biopharma $47 million in near-term cash for a preclinical candidate aimed at gastrointestinal cancers. The ADC in question, dubbed MRG007, has shown “robust ...
Wall Street Pepe’s (WEPE) presale has passed the $55 million milestone ahead of the coin’s first exchange listing. The project, which aims to level the playing field between retail traders and ...
We look forward to collaborating with Lepu Biopharma in advancing this program globally.” Ziye Sui, Ph.D., Executive Director and Chief Executive Officer of Lepu Biopharma added, “We are very ...
Arrivent Biopharma Inc. has entered into an exclusive license agreement with Lepu Biopharma Co. Ltd. for MRG-007, an antibody-drug conjugate (ADC) in development for gastrointestinal cancers. BioWorld ...
US clinical-stage biotech ArriVent BioPharma (Nasdaq: AVBP) has entered into an exclusive license agreement with Shanghai-based Lepu Biopharma (HK: 02157) for MRG007, an antibody-drug conjugate (ADC) ...
Lepu will also be eligible for tiered royalties on net sales outside the Greater China region, should the investigational therapy reach the market. In return, ArriVent will gain the exclusive right to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback